Target Identification, Validation and Screening
AnchorBio can take you from initial target identification and validation, all the way to hit identification and lead optimization.
Assay Design, Development and Validation
-
In vitro and cellular assays
-
Fit-for-purpose validation
-
Screen hundreds of compounds
-
Immuno-based assays
-
Biochemical assays
-
Cell-based Assays
-
Surface Plasmon Resonance (SPR)
-
MS-based assays
Biomarker Discovery and Development
-
Mass Spectrometry-based Proteomics
-
Discovery
-
Targeted
-
Quantitative
-
Neoantigen discovery
-
Plasma/Serum, Cells, Tissues
-
Variant IDs
-
PTM
-
Screening Services
-
Cell-Based Assays
-
Cytokine production
-
Cell viability/proliferation assays
-
Apoptosis
-
Migration
-
Differentiation
-
Signaling pathways
-
Fluorescence-based assays
-
Reporter gene assays
-
Neutrophil extracellular trap (NET) formation
-
Cell morphology assays
-
Surface marker expression
-
-
ELISAs
-
Commercially available
-
Custom
-
-
Biochemical Assays
-
Drug target deconvolution
-
Protein-drug/protein-protein binding studies
-
Small molecule activity screening
-
-
Mass Spectrometry-Based Assays
-
Proteomic phenotypic screening
-
PISA assays (Chemo-proteomics)
-
Activity-based Protein Profiling (ABPP)
-
Discovery
-
Targeted
-
Quantitative
-
Neoantigen discovery
-
Variant IDs
-
PTMs
-